Medtronic plc (MDT) Financial Statements — Income, Balance Sheet, Cash Flow

Overview Financials Chart Business Summary Filings Ownership Valuation

Financial Statements — MDT

Balance Sheet

(in billions USD)

Metric	Q1 2027	Q3 2026	Q2 2026	Q1 2026	Q3 2025	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q3 2023	Q2 2023	Q1 2023	Q3 2022	Q2 2022	Q1 2022	Q3 2021	Q2 2021	Q1 2021
Cash & Equivalents	1.69	1.15	1.28	1.27	1.24	1.39	1.31	1.62	1.31	1.34	4.52	4.83	2.14	3.48	2.90	3.00	5.08	6.42	6.50
Short-term Investments	7.13	7.24	7.05	6.85	6.68	6.60	6.53	6.70	6.42	6.54	6.62	6.60	6.73	7.74	7.77	7.59	9.56	7.86	6.51
Accounts Receivable	6.36	6.36	6.39	6.26	6.12	6.26	6.01	5.97	5.93	5.81	5.89	5.63	5.31	5.45	5.49	5.43	5.22	5.35	4.88
Inventory	6.22	6.31	6.16	5.89	5.61	5.48	5.41	5.73	5.75	5.67	5.38	5.06	4.81	4.51	4.35	4.29	4.51	4.48	4.55
Total Current Assets	24.39	24.07	24.00	23.22	22.51	22.44	21.95	22.51	22.08	21.87	25.36	25.40	22.14	23.30	22.73	22.43	26.35	26.04	24.51
Property, Plant & Equipment	7.47	7.18	7.16	7.01	6.59	6.44	6.28	5.84	5.74	5.67	5.44	5.30	5.28	5.25	5.19	5.16	5.02	4.94	4.88
Goodwill	43.19	41.89	41.81	42.01	40.82	41.16	41.08	41.16	40.82	41.44	41.57	40.42	40.32	41.35	41.61	41.72	42.14	41.21	40.71
Intangible Assets	10.24	10.34	10.77	11.22	12.18	12.42	12.82	13.69	14.06	14.43	15.27	15.66	15.78	16.08	16.52	16.89	18.24	18.41	18.67
Total Non-current Assets*	68.92	67.41	67.35	67.75	67.46	67.60	67.80	68.32	68.01	68.91	68.77	67.84	67.78	68.50	69.03	69.37	70.92	69.85	69.40
Total Assets	93.31	91.49	91.35	90.97	89.97	90.04	89.75	90.84	90.09	90.78	94.13	93.24	89.91	91.80	91.76	91.80	97.27	95.89	93.91
Accounts Payable	2.70	2.57	2.58	2.56	2.29	2.38	2.29	1.99	2.17	2.24	2.21	2.20	2.18	1.99	1.92	1.86	1.82	1.90	1.72
Short-term Debt	2.54	0.19	1.42	2.43	2.62	3.72	1.55	1.03	1.34	0.52	5.92	5.86	5.73	0.87	0.02	0.01	--	--	--
Total Current Liabilities	11.80	9.49	9.94	11.53	11.84	12.20	10.29	9.79	9.66	9.05	14.42	14.47	14.05	8.93	7.80	7.76	12.53	12.07	13.09
Long-term Debt	25.62	27.88	27.68	26.18	23.99	24.61	26.31	24.15	23.74	24.46	22.21	20.75	17.48	24.29	25.61	25.96	26.50	25.97	22.87
Total Non-current Liabilities*	30.66	32.79	32.55	31.31	28.52	29.13	31.30	29.05	28.78	30.36	28.09	26.72	23.02	30.16	31.79	32.37	33.81	33.50	30.38
Total Liabilities	42.46	42.29	42.49	42.84	40.36	41.33	41.59	38.84	38.44	39.41	42.52	41.18	37.07	39.09	39.60	40.14	46.34	45.57	43.46
Retained Earnings	33.19	32.30	32.07	31.61	31.32	30.92	30.55	30.66	30.26	30.27	30.12	29.80	30.28	29.61	28.97	28.51	28.02	27.53	27.82
Total Stockholder Equity	50.23	48.99	48.65	47.89	49.39	48.49	47.95	51.79	51.46	51.18	51.44	51.88	52.67	52.54	51.99	51.49	50.76	50.16	50.30

* Derived from reported values

Income Statement

(in billions USD) (except per-share rows)

Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Total Revenue	9.76	9.81	9.02	8.96	8.58	8.93	8.29	8.40	7.92	8.59	8.09	7.98	7.70	8.54	7.73	7.59	7.37	8.09	7.76	7.85
Cost of Revenue	3.42	3.40	3.26	3.06	3.00	3.15	2.78	2.95	2.76	3.05	2.78	2.76	2.63	2.98	2.69	2.54	2.52	2.59	2.46	2.50
Gross Profit*	6.34	6.41	5.76	5.90	5.58	5.78	16.13	5.46	5.15	5.54	5.31	5.22	5.07	5.57	5.04	5.05	4.86	5.50	5.30	5.35
Selling, General & Admin	3.20	3.06	2.96	2.97	2.81	2.72	2.72	2.76	2.66	2.76	2.67	2.69	2.61	2.62	2.62	2.62	2.57	2.57	2.56	2.62
Total Operating Expenses*	4.58	4.54	4.29	4.21	4.13	4.34	11.61	3.86	3.88	4.49	3.82	3.88	3.81	4.00	3.65	3.65	3.73	3.83	3.65	3.79
Operating Income	1.76	1.87	1.46	1.69	1.45	1.44	1.65	1.60	1.28	1.05	1.48	1.34	1.27	1.56	1.39	1.40	1.13	1.67	1.66	1.56
Interest Expense	--	--	--	--	--	--	--	--	--	0.20	0.19	0.18	0.15	0.19	0.17	0.12	0.16	0.14	0.14	0.14
Pretax Income	1.77	1.83	1.40	1.60	1.30	1.26	1.54	1.56	1.27	0.86	1.47	1.31	1.20	1.55	1.38	1.40	1.04	1.60	1.59	1.49
Tax Provision	0.29	0.57	0.25	0.22	0.26	0.20	0.24	0.28	0.22	0.20	0.14	0.40	0.40	0.36	0.15	0.96	0.11	0.11	0.11	0.18
Net Income	1.47	1.24	1.14	1.37	1.04	1.06	1.29	1.27	1.04	0.65	1.32	0.91	0.79	1.18	1.22	0.43	0.93	1.49	1.48	1.31
Basic EPS	1.15	0.98	0.89	1.07	0.81	0.82	1.01	0.99	0.81	0.51	0.99	0.68	0.59	0.89	0.92	0.32	0.70	1.11	1.10	0.97
Diluted EPS	1.14	0.96	0.89	1.07	0.81	0.81	1.01	0.99	0.80	0.50	0.99	0.68	0.59	0.88	0.92	0.32	0.70	1.10	1.10	0.97

* Derived from reported values

Cash Flow Statement

(in billions USD)

Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Operating Cash Flow	1.79	2.57	2.74	0.93	1.09	2.53	2.57	0.96	0.99	2.78	2.47	0.66	0.88	2.46	1.57	0.92	1.08	2.06	2.23	1.77
Capital Expenditures	0.50	0.49	0.44	0.47	0.50	0.46	0.48	0.40	0.52	0.43	0.35	0.46	0.35	0.38	0.33	0.32	0.43	0.39	0.33	0.27
Free Cash Flow*	1.29	2.09	2.30	0.46	0.58	2.07	2.10	0.55	0.47	2.35	2.13	0.20	0.52	2.08	1.24	0.60	0.66	1.67	1.90	1.50
Investing Cash Flow	(1.62)	(0.92)	(0.82)	(0.48)	(0.72)	(0.49)	(0.84)	(0.34)	(0.26)	(0.70)	(0.71)	(0.42)	(0.54)	(0.47)	(0.29)	(1.15)	(1.58)	0.27	(0.44)	(0.71)
Financing Cash Flow	(0.34)	(0.89)	(2.09)	(0.39)	(1.38)	(1.34)	(1.75)	(0.53)	(0.73)	(2.36)	(1.50)	(0.09)	(0.50)	(4.89)	(2.13)	3.01	(0.95)	(1.95)	(1.18)	(1.15)

* Derived from reported values

Dividends Per Share

(USD)

Metric	Q1 2027	Q4 2026	Q3 2026	Q2 2026	Q1 2026	Q4 2025	Q3 2025	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022
Dividends Per Share	0.72	0.71	0.71	0.71	0.71	0.70	0.70	0.70	0.70	0.69	0.69	0.69	0.69	0.68	0.68	0.68	0.68	0.63	0.63	0.63